| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.08M | $6.93M | - | |
| VP | 300.8K | $1.93M | - | |
| CFO | 295.3K | $900.7K | - | |
| Other | 189.4K | $1.22M | - | |
| Other | 100.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 14,340 | $20.60 | $295,404.00 | -75.5% | |
| Nov 1, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 14,342 | $19.86 | $284,832.12 | -77.2% | |
| Nov 1, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $20.00 | $50,000.00 | -17.1% | |
| Oct 4, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 19,120 | $24.13 | $461,365.60 | -81.8% | |
| Oct 4, 2017 | Kavanaugh William Michael | CSO, Head Res.&Non-clin. Dev. | Sale+OE | 48,368 | $24.34 | $1,177,277.12 | -77.7% | |
| Oct 4, 2017 | Tepper Robert I | 10% Owner | Sell | 24,777 | $24.34 | $603,072.18 | -45.6% | |
| Oct 4, 2017 | Gluck Frederick W | Director | Sell | 10,000 | $24.27 | $242,680.00 | -3.1% | |
| Oct 2, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $18.10 | $45,250.00 | -14.6% | |
| Oct 2, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 9,562 | $18.57 | $177,566.34 | -69.3% | |
| Sep 26, 2017 | Gluck Frederick W | Director | Sell | 5,000 | $17.30 | $86,476.00 | -1.5% |